сряда, 11 август 2021 г.

Weekly Update: New diabetes clinical trial (14 items)

New diabetes clinical trial: A Multiple-Dose Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Published on: July 12, 2021 at 07:00PM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Insulin Glargine;   Drug: LY3209590
Sponsor:   Eli Lilly and Company
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04957914?term=diabetes&sfpd_d=14 July 12, 2021 at 05:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study

Published on: July 12, 2021 at 07:00PM
Conditions:   Type1diabetes;   Celiac Disease
Intervention:  
Sponsor:   University of Helsinki
Active, not recruiting
https://clinicaltrials.gov/ct2/show/NCT04958356?term=diabetes&sfpd_d=14 July 12, 2021 at 05:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Multiprofessional Approach in Diabetes Mellitus

Published on: July 12, 2021 at 07:00PM
Condition:   Diabetes Mellitus, Type 2
Intervention:   Behavioral: Specific and educational guidelines on care for pathology (diabetes mellitus) according to each profession involved in the research
Sponsor:   Leonardo Paroche de Matos
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04958980?term=diabetes&sfpd_d=14 July 12, 2021 at 05:24PM

via ClinicalTrials.gov


New diabetes clinical trial: FSL2 Post Approval Study for Pediatric Patients

Published on: July 13, 2021 at 07:00PM
Condition:   Diabete Mellitus
Intervention:   Device: FreeStyle Libre 2
Sponsor:   Abbott Diabetes Care
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04959552?term=diabetes&sfpd_d=14 July 13, 2021 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Changing Health Through Food Support for Diabetes

Published on: July 13, 2021 at 07:00PM
Conditions:   Type 2 Diabetes;   Food Insecurity
Interventions:   Other: Food support;   Other: Nutritional Counseling and education
Sponsors:   University of California, San Francisco;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Project Open Hand
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04959487?term=diabetes&sfpd_d=14 July 13, 2021 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Prospective Decision Impact Trial of KidneyIntelX

Published on: July 14, 2021 at 07:00PM
Conditions:   Diabetic Kidney Disease;   Chronic Kidney Disease Stage 1;   Chronic Kidney Disease Stage 2;   Chronic Kidney Disease, Stage 3 (Moderate)
Intervention:   Diagnostic Test: KidneyIntelX
Sponsor:   Renalytix AI, Inc.
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04960514?term=diabetes&sfpd_d=14 July 14, 2021 at 06:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Prebiotics in Newly Diagnosed Type 1 Diabetes

Published on: July 15, 2021 at 07:00PM
Condition:   Type 1 Diabetes
Interventions:   Dietary Supplement: Prebiotic;   Dietary Supplement: Placebo
Sponsor:   University of Calgary
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04963777?term=diabetes&sfpd_d=14 July 15, 2021 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes

Published on: July 15, 2021 at 07:00PM
Condition:   Type 1 Diabetes
Intervention:   Device: MiniMed™ 780G insulin pump with Klue Health app utilizing meal gesture micro insulin dosing (meal gesture dosing)
Sponsor:   Medtronic Diabetes
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04964128?term=diabetes&sfpd_d=14 July 15, 2021 at 04:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Distinguishing Patient Groups Using Autonomic Dysfunction

Published on: July 16, 2021 at 07:00PM
Condition:   Diabetes
Intervention:   Other: Device: ANSiScope Plus
Sponsor:   DyAnsys, Inc.
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04964921?term=diabetes&sfpd_d=14 July 16, 2021 at 05:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

Published on: July 16, 2021 at 07:00PM
Conditions:   Type 1 Diabetes Mellitus With Diabetic Gastroparesis;   HbA1c;   Time in Range
Interventions:   Drug: insulin degludec/insulin aspart (IDegAsp);   Drug: basal insulin plus pre-prandial insulin
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
https://clinicaltrials.gov/ct2/show/NCT04965051?term=diabetes&sfpd_d=14 July 16, 2021 at 05:24PM

via ClinicalTrials.gov


New diabetes clinical trial: A Multicenter Clinical Study of Echocardiographic Assessment of Right Heart Function and Implications of Prognosis in Diabetes

Published on: July 16, 2021 at 07:00PM
Conditions:   Diabetes;   Prognosis
Intervention:  
Sponsors:   Xie Mingxing;   Second Affiliated Hospital, School of Medicine, Zhejiang University;   Shanghai Zhongshan Hospital;   Henan Provincial People's Hospital;   Wuhan Asia Heart Hospital;   Guangdong Provincial People's Hospital
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04964713?term=diabetes&sfpd_d=14 July 16, 2021 at 05:24PM

via ClinicalTrials.gov


New diabetes clinical trial: A Study of IBI362 in Chinese Patients With Type 2 Diabetes

Published on: July 16, 2021 at 07:00PM
Condition:   Type 2 Diabetes
Interventions:   Drug: IBI362;   Other: placebo;   Other: Dulaglutide
Sponsor:   Innovent Biologics (Suzhou) Co. Ltd.
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04965506?term=diabetes&sfpd_d=14 July 16, 2021 at 05:24PM

via ClinicalTrials.gov


New diabetes clinical trial: A Study of the Continuous Glucose Monitoring System for Home Use in Patients With Diabetes

Published on: July 16, 2021 at 07:00PM
Condition:   Diabetes
Intervention:   Device: continuous glucose-monitoring
Sponsors:   Lee's Pharmaceutical Limited;   Powder (Guangzhou) Pharmaceuticals Limited;   Powder Pharmaceuticals (HK) Co., Ltd
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04964752?term=diabetes&sfpd_d=14 July 16, 2021 at 05:24PM

via ClinicalTrials.gov


New diabetes clinical trial: Effect of GLP-1 Receptor Agonists on Trabecular Bone Score and Visceral Adiposity in Postmenopausal Women With Type 2 Diabetes Mellitus.

Published on: July 16, 2021 at 07:00PM
Conditions:   Osteoporosis, Postmenopausal;   Diabetes Mellitus, Type 2
Intervention:   Drug: GLP-1 receptor agonist
Sponsor:   University of Mississippi Medical Center
Not yet recruiting
https://clinicaltrials.gov/ct2/show/NCT04964388?term=diabetes&sfpd_d=14 July 16, 2021 at 05:24PM

via ClinicalTrials.gov


Няма коментари:

Публикуване на коментар